Skip NavigationSkip to Content
Return Return to Search Results

Hepatitis B and C virus infection and the risk of biliary tract cancer: A population-based study in China

  1. Author:
    Hsing, A. W.
    Zhang, M.
    Rashid, A.
    McGlynn, K. A.
    Wang, B. S.
    Niwa, S.
    Ortiz-Conde, B. A.
    Goedert, J. J.
    Fraumeni, J. F.
    O'Brien, T. R.
    Gao, Y. T.

  2. Author Address

    Hsing, Ann W.; McGlynn, Katherine A.; Goedert, James J.; Fraumeni, Joseph F., Jr.; O'Brien, Thomas R.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20852 USA. [Zhang, Mingdong] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China. [Rashid, Asif] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA. [Wang, Bing-Shen] Shanghai Med Univ, Zhongshan Hosp, Dept Surg, Shanghai 200032, Peoples R China. [Niwa, Shelley] Westat Corp, Rockville, MD USA. [Ortiz-Conde, Betty A.] NCI Frederick, Viral Epidemiol Sect, AIDS Vaccine Program, SAIC Frederick, Frederick, MD USA. [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China.
    1. Year: 2008
  2. Journal: International Journal of Cancer
    1. 122
    2. 8
    3. Pages: 1849-1853
  4. Type of Article: Article
  1. Abstract:

    Emerging data suggest that chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections may also play a role in extrahepatic bile duct cancers. To test the HBV hypothesis, we examined the relationship of HBV/HCV infection with risks of biliary tract cancer and biliary stones in a population-based case-control study conducted in Shanghai, China. Standard assays were used to detect HBV surface antigen (HBsAg) and antibodies against HBV core antigen (anti-HBc) and hepatitis C virus (anti-HCV) in sera from 417 patients with biliary tract cancers, 517 with biliary stones, and 762 healthy controls randomly selected from the population. Unconditional logistic regression was used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) for each disease type. HBsAg seroprevalence was 7.3% among population controls and 14.2% among patients with extrahepatic bile duct cancer, resulting in a 2.4-fold risk of extrahepatic bile duct cancer (95% CI 1.2-4.5). No association was found for cancers of the gallbladder (prevalence 8.2%) or the ampulla of Vater (6.1%), or for stones in the gallbladder (10.1%) or bile duct (9.3%). Further adjustment for education, smoking, body mass index, diabetes and gallstones did not materially change the results. Prevalence of HCV infection in this population was low (2%), limiting our ability to detect an association with biliary diseases. In Shanghai, an HBV endemic area, chronic HBV infection was associated with a 2.4-fold risk of extrahepatic bile duct cancer. These results should be confirmed in other populations with varying risks of HBV and HCV infection. (c) 2007 Wiley-Liss, Inc.

    See More

  1. Keywords:

External Sources

  1. PMID: 18076042

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel